Clinical Trial Update: A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]

View source ↗

Summary

A Phase I clinical trial update announcing recruitment for SHR-2005 intravesical instillation in patients with intermediate- and high-risk non-muscle invasive b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• SHR-2005

Snippet

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Conditions: Intermediate and High-risk Non-muscle Invasive Bladder Cancer | Phase 1 | Status: RECRUITING